. 2024 Jul 9;22(1):48.

doi: 10.1186/s12955-024-02256-9.

Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024

Ellen B M Elsman^{1

2}, Lidwine B Mokkink², Caroline B Terwee², Dorcas Beaton³, Joel J Gagnier⁴, Andrea C Tricco^{5

6

7}, Ami Baba¹, Nancy J Butcher^{1

8}, Maureen Smith⁹, Catherine Hofstetter¹⁰, Olalekan Lee Aiyegbusi¹¹, Anna Berardi^{12

13}, Julie Farmer¹⁴, Kirstie L Haywood¹⁵, Karolin R Krause¹⁶, Sarah Markham¹⁷, Evan Mayo-Wilson¹⁸, Ava Mehdipour¹⁹, Juanna Ricketts^#²⁰, Peter Szatmari¹⁶, Zahi Touma²¹, David Moher²², Martin Offringa^{23

24}

Affiliations

¹ Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, ON, Canada.
² Department of Epidemiology and Data Science, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, Netherlands.
³ Institute of Work and Health, Toronto, ON, Canada.
⁴ Department of Epidemiology & Biostatistics and Department of Surgery, Western University, London, ON, Canada.
⁵ Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, Toronto, ON, Canada.
⁶ Epidemiology Division and Institute of Health Policy, Management, and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
⁷ Queen's Collaboration for Health Care Quality Joanna Briggs Institute Centre of Excellence, Queen's University, Kingston, Canada.
⁸ Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
⁹ Cochrane Consumer Network, London, UK.
¹⁰ OMERACT Patient Research Partner, Toronto, ON, Canada.
¹¹ Centre for Patient Reported Outcomes Research, Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
¹² Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy.
¹³ IRCCS NEUROMED, Pozzilli, Isernia, Italy.
¹⁴ Faculty of Dentistry, University of Toronto, Toronto, ON, Canada.
¹⁵ Warwick Research in Nursing, Division of Health Sciences, Warwick Medical School, University of Warwick, Gibbet Hill, Coventry, UK.
¹⁶ Cundill Centre for Child and Youth Depression, Centre for Addiction and Mental Health, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.
¹⁷ Department of Biostatistics & Health Informatics, Institute of Psychiatry Psychology & Neuroscience (IoPPN), King's College London, London, UK.
¹⁸ Department of Epidemiology, UNC Gillings School of Global Public Health, 2101C McGavran-Greenberg Hall Chapel Hill, Chapel Hill, NC, 27599, USA.
¹⁹ School of Rehabilitation Science, Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada.
²⁰ Patient Partner, Halifax, NS, Canada.
²¹ Division of Rheumatology, Department of Medicine, Schroeder Arthritis Institute, Krembil Research Institute, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada.
²² Centre for Journalology, Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
²³ Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, ON, Canada. martin.offringa@sickkids.ca.
²⁴ Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada. martin.offringa@sickkids.ca.

^# Contributed equally.

PMID: 38978063
PMCID: PMC11232333
DOI: 10.1186/s12955-024-02256-9

Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024

Ellen B M Elsman et al. Health Qual Life Outcomes. 2024.

. 2024 Jul 9;22(1):48.

doi: 10.1186/s12955-024-02256-9.

Authors

Affiliations

¹ Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, ON, Canada.
² Department of Epidemiology and Data Science, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, Netherlands.
³ Institute of Work and Health, Toronto, ON, Canada.
⁴ Department of Epidemiology & Biostatistics and Department of Surgery, Western University, London, ON, Canada.
⁵ Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, Toronto, ON, Canada.
⁶ Epidemiology Division and Institute of Health Policy, Management, and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
⁷ Queen's Collaboration for Health Care Quality Joanna Briggs Institute Centre of Excellence, Queen's University, Kingston, Canada.
⁸ Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
⁹ Cochrane Consumer Network, London, UK.
¹⁰ OMERACT Patient Research Partner, Toronto, ON, Canada.
¹¹ Centre for Patient Reported Outcomes Research, Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
¹² Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy.
¹³ IRCCS NEUROMED, Pozzilli, Isernia, Italy.
¹⁴ Faculty of Dentistry, University of Toronto, Toronto, ON, Canada.
¹⁵ Warwick Research in Nursing, Division of Health Sciences, Warwick Medical School, University of Warwick, Gibbet Hill, Coventry, UK.
¹⁶ Cundill Centre for Child and Youth Depression, Centre for Addiction and Mental Health, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.
¹⁷ Department of Biostatistics & Health Informatics, Institute of Psychiatry Psychology & Neuroscience (IoPPN), King's College London, London, UK.
¹⁸ Department of Epidemiology, UNC Gillings School of Global Public Health, 2101C McGavran-Greenberg Hall Chapel Hill, Chapel Hill, NC, 27599, USA.
¹⁹ School of Rehabilitation Science, Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada.
²⁰ Patient Partner, Halifax, NS, Canada.
²¹ Division of Rheumatology, Department of Medicine, Schroeder Arthritis Institute, Krembil Research Institute, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada.
²² Centre for Journalology, Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
²³ Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, ON, Canada. martin.offringa@sickkids.ca.
²⁴ Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada. martin.offringa@sickkids.ca.

^# Contributed equally.

PMID: 38978063
PMCID: PMC11232333
DOI: 10.1186/s12955-024-02256-9

Abstract

Purpose: Although comprehensive and widespread guidelines on how to conduct systematic reviews of outcome measurement instruments (OMIs) exist, for example from the COSMIN (COnsensus-based Standards for the selection of health Measurement INstruments) initiative, key information is often missing in published reports. This article describes the development of an extension of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guideline: PRISMA-COSMIN for OMIs 2024.

Methods: The development process followed the Enhancing the QUAlity and Transparency Of health Research (EQUATOR) guidelines and included a literature search, expert consultations, a Delphi study, a hybrid workgroup meeting, pilot testing, and an end-of-project meeting, with integrated patient/public involvement.

Results: From the literature and expert consultation, 49 potentially relevant reporting items were identified. Round 1 of the Delphi study was completed by 103 panelists, whereas round 2 and 3 were completed by 78 panelists. After 3 rounds, agreement (≥ 67%) on inclusion and wording was reached for 44 items. Eleven items without consensus for inclusion and/or wording were discussed at a workgroup meeting attended by 24 participants. Agreement was reached for the inclusion and wording of 10 items, and the deletion of 1 item. Pilot testing with 65 authors of OMI systematic reviews further improved the guideline through minor changes in wording and structure, finalized during the end-of-project meeting. The final checklist to facilitate the reporting of full systematic review reports contains 54 (sub)items addressing the review's title, abstract, plain language summary, open science, introduction, methods, results, and discussion. Thirteen items pertaining to the title and abstract are also included in a separate abstract checklist, guiding authors in reporting for example conference abstracts.

Conclusion: PRISMA-COSMIN for OMIs 2024 consists of two checklists (full reports; abstracts), their corresponding explanation and elaboration documents detailing the rationale and examples for each item, and a data flow diagram. PRISMA-COSMIN for OMIs 2024 can improve the reporting of systematic reviews of OMIs, fostering their reproducibility and allowing end-users to appraise the quality of OMIs and select the most appropriate OMI for a specific application. NOTE: In order to encourage its wide dissemination this article is freely accessible on the web sites of the journals: Health and Quality of Life Outcomes; Journal of Clinical Epidemiology; Journal of Patient-Reported Outcomes; Quality of Life Research.

Keywords: COSMIN; Measurement properties; Outcome measurement instrument; PRISMA; Reporting guideline; Systematic reviews.

PubMed Disclaimer

Conflict of interest statement

Drs. Terwee and Mokkink are the founders of COSMIN; Dr. Moher is a member of the PRISMA executive; Dr. Tricco is the co-editor in chief of the Journal of Clinical Epidemiology. The other authors have no conflicts of interest.

Figures

**Fig. 1**
Development process of PRISMA-COSMIN for OMIs 2024. *E&E* explanation and elaboration; *EQUATOR* Enhancing the QUAlity and Transparency Of health Research; *OMI* outcome measurement instrument

**Fig. 2**
Proposals and consensus for items in each Delphi round and the workgroup meeting. *COSMIN* COnsensus-based Standards for the selection of health Measurement Instruments; *OMI* outcome measurement instrument; *PRISMA* Preferred Reporting Items for Systematic reviews and Meta-Analyses

**Fig. 3**
PRISMA-COSMIN for OMIs 2024 flow diagram

See this image and copyright information in PMC

Cited by

A systematic review of patient-reported outcome measures (PROMs) to assess health-related quality of life (HRQoL) for breast cancer patients who are undertaking adjuvant endocrine therapy.
Su R, Snyder C, Wu AW, Gross AL, Ji J, Zhang J, Morlock L. Su R, et al. Qual Life Res. 2025 Jun 18. doi: 10.1007/s11136-025-04004-y. Online ahead of print. Qual Life Res. 2025. PMID: 40533702
COSMIN reporting guideline for studies on measurement properties of patient‑reported outcome measures: version 2.0.
Gagnier JJ, de Arruda GT, Terwee CB, Mokkink LB; Consensus group. Gagnier JJ, et al. Qual Life Res. 2025 Jul;34(7):1901-1911. doi: 10.1007/s11136-025-03950-x. Epub 2025 Mar 28. Qual Life Res. 2025. PMID: 40153128
Patient-reported outcome measures for fatigue in patients with chronic kidney disease: a systematic review.
Hughes A, Ju A, Cazzolli R, Howell M, Guha C, Levin A, Manera K, Teixeira-Pinto A, Torrisi LG, Wheeler DC, Wong G, Wu R, Jaure A. Hughes A, et al. BMJ Open. 2025 Jul 16;15(7):e099592. doi: 10.1136/bmjopen-2025-099592. BMJ Open. 2025. PMID: 40669903 Free PMC article.
Selection of patient-reported outcome measures in pulmonary arterial hypertension clinical trials: a systematic review, meta-analysis and health-related quality of life framework.
Varian F, Burney R, Pearson C, Goh ZM, Newman J, Rawlings G, Zafar H, Kiely DG, Thompson AAR, Condliffe R, Toshner M, McCormack C, Armstrong I, Peasgood T, Carlton J, Rothman AMK. Varian F, et al. Eur Respir Rev. 2025 May 14;34(176):250006. doi: 10.1183/16000617.0006-2025. Print 2025 Apr. Eur Respir Rev. 2025. PMID: 40368429 Free PMC article.
Comparability, acceptability and longitudinal adherence with digital emPHasis-10 in pulmonary arterial hypertension.
Newman J, Varian F, Hitchcock F, Burney R, Rawlings GH, Harrington J, Goh ZM, Ablott J, Kiely DG, Armstrong I, Thompson AAR, Carlton J, Davies EH; National Cohort Study of Pulmonary Hypertension Collaboration, UniPHy Clinical Trials Network; Rothman A, Toshner M. Newman J, et al. Eur Respir J. 2025 Jun 19;65(6):2500198. doi: 10.1183/13993003.00198-2025. Print 2025 Jun. Eur Respir J. 2025. PMID: 40404213 Free PMC article.

References

1. Butcher NJ, Monsour A, Mew EJ, Chan A-W, Moher D, Mayo-Wilson E, Terwee CB, Chee-A-Tow A, Baba A, Gavin F. Guidelines for reporting outcomes in trial reports: The CONSORT-outcomes 2022 extension. JAMA. 2022;328(22):2252–2264. - PubMed
1. Prinsen CA, Mokkink LB, Bouter LM, Alonso J, Patrick DL, De Vet HC, Terwee CB. COSMIN guideline for systematic reviews of patient-reported outcome measures. Qual Life Res. 2018;27(5):1147–1157. - PMC - PubMed
1. Porter ME. What is value in health care. N Engl J Med. 2010;363(26):2477–2481. - PubMed
1. Nelson, E. C., Eftimovska, E., Lind, C., Hager, A., Wasson, J. H., & Lindblad, S. (2015). Patient reported outcome measures in practice. BMJ. 10.1136/bmj.g7818 - PubMed
1. OMERACT . The OMERACT handbook for establishing and implementing core outcomes in clinical trials across the spectrum of rheumatologic conditions. OMERACT; 2021.

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

452145/CAPMC/ CIHR/Canada

LinkOut - more resources

Full Text Sources
- BioMed Central
- PubMed Central

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024

Affiliations

Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024

Authors

Affiliations

Abstract

Conflict of interest statement

Figures

Similar articles

Cited by

References

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources

Abstract

Conflict of interest statement

Figures

Similar articles

Cited by

References

MeSH terms

Related information

Grants and funding

LinkOut - more resources

Full Text Sources